Trials / Completed
CompletedNCT03634735
Thiamin Against Robust IBD Fatigue
- Status
- Completed
- Phase
- Phase 4
- Study type
- Interventional
- Enrollment
- 40 (actual)
- Sponsor
- University of Aarhus · Academic / Other
- Sex
- All
- Age
- 18 Years
- Healthy volunteers
- Not accepted
Summary
Patients with Inflammatory Bowel Disease (IBD), disease in remission and chronic fatigue will receive oral Thiamine treatment for 4 weeks in a RCT, cross-over study.
Detailed description
Patients with Inflammatory Bowel Disease (IBD), disease in remission and chronic fatigue will receive high dose oral Thiamine treatment for 4 weeks in a RCT, cross-over study. After the high dose treatment period, participants will be randomized to 3 months treatment with Thiamine 300mg/day or placebo.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | Thiamine | Vitamine B1 |
| OTHER | Placebo | Placebo tablets |
Timeline
- Start date
- 2018-11-27
- Primary completion
- 2020-04-21
- Completion
- 2020-10-27
- First posted
- 2018-08-16
- Last updated
- 2020-10-29
Locations
1 site across 1 country: Denmark
Source: ClinicalTrials.gov record NCT03634735. Inclusion in this directory is not an endorsement.